Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 8, 1996, Pages 984-991

  Tonstad, Serena ^a   Joakimsen, Oddmund ^b   Stensland Bugge, Eva ^b   Leren, Trond P ^c   Ose, Leiv ^a   Russell, David ^a   Bønaa, Kaare H ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

carotid arteries; children; familial hypercholesterolemia; homocysteine; ultrasonography

Indexed keywords

APOLIPOPROTEIN B; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; ECHOGRAPHY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

EID: 0029791893     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.8.984     Document Type: Article

References (65)

1. National Cholesterol Education Program. Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics. 1992;89:525-584.
2. Widhalm K. Paediatric guidelines for lipid reduction. Eur Heart J. 1987;8(suppl E):65-70.
3. Kaplan RM, Toshima MT. Does a reduced fat diet cause retardation in child growth? Prev Med. 1992;21:33-52.
4. West RJ, Lloyd JK. Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine. Lancet. 1980;2:873-875.
5. Levine GN, Keaney JF Jr, Vita JA. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med. 1995;332:512-521.
6. Ose L, Tonstad S. The detection and management of dyslipidaemia in children and adolescents. Acta Pædiatr. 1995;84:1213-1215.
7. Heiberg A, Slack J. Family similarities in the age at coronary death in familial hypercholesterolaemia. BMJ. 1977;2:493-495.
8. Hill JS, Hayden MR, Frohlich J, Pritchard PH. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Arterioscler Thromb. 1991;11:290-297.
9. Ferrières J, Lambert J, Lussier-Cacan S, Davignon J, Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Circulation. 1995;92:290-295.
10. Grobbee DE, Bots ML. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med. 1994;236:567-573.
11. Wofford JL, Kahl FR, Howard GR, McKinney WM, Toole JF, Crouse JR III. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb. 1991;11:1786-1794.
12. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993;87(suppl II): II-56-II-65.
13. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med. 1991;229:225-231.
14. Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE, for the ARIC Investigators. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. Arterioscler Thromb. 1994; 14:1098-1104.
15. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. Circulation. 1993;87:1107-1113.
16. Folsom AR, Wu KK, Shahar E, Davis CE, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb. 1993;13:1829-1836.
17. Joakimsen O, Bønaa KH, Stensland-Bugge E. Does diabetes mellitus remove the protective effect of female sex in the development of carotid atherosclerosis? Initial findings from the Tromsø study. In: Touboul P-J, ed. Proceedings of the First International Symposium: Watching the Risk: From Arterial Wall Thickening to Clinical Symptoms. Paris, France: 1995:46. Abstract.
18. Stensland-Bugge E, Bønaa KH, Joakimsen O, Førde OH, Arnesen E. 15 Year population-based prospective study of ultrasonographically assessed carotid atherosclerosis: initial findings from the Tromsø study. In: Touboul P-J, ed. Proceedings of the First International Symposium: Watching the Risk: From Arterial Wall Thickening to Clinical Symptoms. Paris, France: 1995:46. Abstract.
19. Pauciullo P, Iannuzzi A, Sartorio R, Irace C, Covetti G, Costanzo AD, Rubba P. Increased intima-media thickness of the common carotid artery in hypercholesterolemic children. Arterioscler Thromb. 1994;14:1075-1079.
20. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis. 1989;9(suppl I):I-19-I-32.
21. Leren TP, Solberg K, Rødningen OK, Tonstad S, Ose L. Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects. Atherosclerosis. 1994;111:175-182.
22. Sundvold H, Solberg K, Tonstad S, Redningen OK, Ose L, Berg K, Leren TP. A common missense mutation (C2I0G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects. Hum Mutat. 1996;7:70-71.
23. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1992;1:445-466.
24. Leren TP, Sundvold H, Rødningen OK, Tonstad S, Solberg K, Ose L, Berg K. Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia. Hum Genet. 1995;95:671-676.
25. Leren TP, Solberg K, Rødningen OK, Tonstad S, Ose L. Two novel point mutations in the EGF precursor homology domain of the LDL receptor gene causing familial hypercholesterolemia. Hum Genet. 1995;96:241-242.
26. Tanner JM, Growth at Adolescence. 2nd ed. Oxford, UK: Blackwell; 1962.
27. Hoeg JM, Feuerstein IM, Tucker EE. Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia. Arterioscler Thromb. 1994;14:1066-1074.
28. Eiklid K, Leren TP. Genotyping of apolipoprotein E. J Norweg Med Assoc. 1993;113:1885.
29. Refsum H, Ueland PM, Svardal AM. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem. 1989;35:1921-1927.
30. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem. 1993;39:263-271.
31. Wendelhag I, Gustavsson T, Suurküla M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol. 1991;11:565-577.
32. Bostom AG, Gagnon DR, Cupples A, Wilson PWF, Jenner JL, Ordovas JM, Schaefer EJ, Castelli WP. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women: the Framingham Heart Study. Circulation. 1994;90:1688-1695.
33. Tonstad S, Refsum H, Sivertsen M, Christophersen B, Ose L, Ueland PM. Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatr Res. In press.
34. Newman WP III, Wattigney W, Berenson GS. Autopsy studies in United States children and adolescents. Ann N Y Acad Sci. 1991;623:16-25.
35. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum upoprotein cholesterol concentrations and smoking. JAMA. 1990;264;3018-3024.
36. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. Atherosclerosis. 1988;70:253-261.
37. Bonithon-Kopp C, Scarabin PY, Taquet A, Touboul P-J, Malmejac A, Guize L. Risk factors for early carotid atherosclerosis in middle-aged French women. Arterioscler Thromb. 1991;11:966-972.
38. Giral P, Pithois-Merli I, Filitti V, Levenson J, Plainfosse MC, Mainardi C, Simon AC, Prévention Cardio-vasculaire en Médecine du Travail METRA Group. Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men. Arch Intern Med. 1991;151:950-956.
39. Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. Arterioscler Thromb. 1993;13:661-668.
40. Salonen JT, Salonen R. Risk factors for carotid and femoral atherosclerosis in hypercholesterolaemic men. J Intern Med. 1994;236:561-566.
41. Gariepy J, Simon A, Massonneau M, Linhart A, Levenson J, PCVMETRA Group. Wall thickening of carotid and femoral arteries in male subjects with isolated hypercholesterolemia. Atherosclerosis. 1995;113:141-151.
42. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK, Bommer W, Price TR, Gardin JM, Savage PJ, on Behalf of the CHS Collaborative Research Group. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke. 1992;23:1752-1760.
43. Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis. 1990;81:33-40.
44. Blankenhorn DH, Selzer RH, Crawford DW, Barth JD, Liu C, Liu C, Mack WJ, Alaupovic P. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Circulation. 1993;88:20-28.
45. Furberg CD, Adams HP Jr, Applegate WB, Byington RP, Espeland MA, Hartwell T, Hunninghake DB, Lefkowitz DS, Probstfield J, Riley WA, Young B, for the Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation. 1994;90:1679-1687.
46. Grouse JR III, Byington RP, Bond MG, Espeland MA, Craven TE, Sprinkle JW, McGovern ME, Furberg CD. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol. 1995;75:455-459.
47. Wendelhag I, Wiklund O, Wikstrand J. Arterial wall thickness in familial hypercholesterolemia: ultrasound measurement of intimamedia thickness in the common carotid artery. Arterioscler Thromb. 1992;12:70-77.
48. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, Burke GL, for the ARIC Investigators. Carotid artery intimalmedial thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke. 1993;24:1297-1304.
49. Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi F, Feruglio GA, Touboul P-J. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992;23:1705-1711.
50. Tonstad S, Leren TP, Sivertsen M, Ose L. Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway. Arterioscler Thromb Vasc Biol. 1995;15:1009-1014.
51. Postiglione A, Rubba P, De Simene B, Patti L, Cicerano U, Mancini M. Carotid atherosclerosis in familial hypercholesterolemia. Stroke. 1985;16:658-661.
52. Hixson JE and the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb. 1991;11:1237-1244.
53. Tiret L, de Knijff P, Menzel H-J, Ehnholm C, Nicaud V, Havekes LM for the EARS group. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. Arterioscler Thromb. 1994;14:1617-1624.
54. Berglund L, Wiklund O, Eggertsen G, Olofsson S-O, Eriksson M, Lindén T, Bondjers G, Angelin B. Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy. J Intern Med. 1993;233:173-178.
55. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent vasodilation is an early event in children with familial hypercholesterolemia, and is related to the Lp (a) level. J Clin Invest. 1994;93:50-55.
56. Tatò F, Keller C, Schuster H, Spengel F, Wolfram G, Zöllner N. Relation of lipoprotein(a) to coronary heart disease and duplexsonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia. Atherosclerosis. 1993;101:69-77.
57. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286-291.
58. Arnesen E, Refsum H, Bønaa KH, Ueland PM, Førde OH, Nordrehaug JE. The Tromso study: a population based prospective study of serum total homocysteine and coronary heart disease. Int J Epidemiol. 1995;24:704-709.
59. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, Kottke-Marchant K, Savon SR, Selhub J, Nissen SE, Kutner M, Topol EJ, Jacobsen DW. Hyperhomocysteinemia and low pyridoxal phosphate. Circulation. 1995;92:2825-2830.
60. Tonstad S, Sivertsen M, Aksnes L, Ose L. Low dose colestipol in adolescents with familial hypercholesterolaemia. Arch Dis Child. 1996;74:157-160.
61. West RJ, Lloyd JK. The effect of cholestyramine on intestinal absorption. Gut. 1975;16:93-98.
62. Betteridge DJ. Lipid disorders. In: Brook CGD, ed. Paediatric Endocrinology. 3rd ed. Oxford, UK: Blackwell Science; 1995:694-712.
63. Wu KK, Folsom AR, Heiss G, Davis CE, Conlan MG, Barnes R, for the ARIC Study Investigators. Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Ann Epidemiol. 1992;2:471-480.
64. Solberg LA, Eggen DA. Localization and sequence of development of atherosclerotic lesions in the carotid and vertebral arteries. Circulation. 1971;43:711-724.
65. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Arterioscler Thromb. 1993;13:1404-1411.